why choose us

First received: May 31, 2024

Clinical Trial: Safety and Immunogenicity Trial of MPV/S-2P SARS-CoV-2 Vaccine in Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: COVID-19

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Open-Label Safety and Immunogenicity Trial of MPV/S-2P, a Next Generation SARS-CoV-2 Booster Vaccine, in Previously Vaccinated Adults

Brief Summary: A clinical trial to evaluate the safety, reactogenicity, and immunogenicity of MPV/S-2P administered intranasally to adults who have previously received a primary series and at least one booster with an authorized or licensed mRNA SARS-CoV-2 parenteral vaccine.The primary objective is to evaluate the safety and reactogenicity of a single dose of MPV/S-2P in previously vaccinated healthy adults.

Read more